Game changer in heart health: EW CEO

8:33 AM ET Mon, 4 April 2016

Michael Mussallem, Edwards Lifesciences CEO, talks about recent data on transcathether heart valves which show a minimally invasive procedure to replace the aortic heart valve is superior to open-heart surgery for patients with certain risks of complications.